$2.36
+0.04 (+1.72%)
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+907.6% upside
Low Target
$21.93
Average Target
$23.78
High Target
$37.21
Current Price
$2.36
Current
$2.36
$2.36
Target
$23.78
$23.78
$21.93
$23.78 avg
$37.21
Scenario Analysis
Bear Case
$21.93
829.2%
Low target
Base Case
$23.78
+907.6%
Avg target
Bull Case
$37.21
+1,476.7%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$4.00
-41.0% from high
52-Week Low
$2.03
+16.3% from low
Target vs 52W High
$23.78
+494.5% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 79% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -11.6% |
| REGN | Buy | 38 | 71% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 44 | 64% | $91.45 | -56.0% |